FIELD: medicine; pharmaceuticals.
SUBSTANCE: invention relates to PDE1 activity inhibitors of formula I (values of radicals are indicated in the claims) in free form or in form of a pharmaceutically acceptable salt, to methods for their production, to methods for treating diseases associated with inhibitory PDE1 activity, and to pharmaceutical compositions containing these compounds.
(I).
EFFECT: treating diseases associated with inhibitory PDE1 activity.
21 cl, 9 ex, 1 tbl
| Title | Year | Author | Number |
|---|---|---|---|
| METHODS OF TREATMENT | 2020 |
|
RU2822394C1 |
| COMPOUNDS AND METHODS | 2015 |
|
RU2711442C2 |
| USING SIP RECEPTOR MODULATOR | 2008 |
|
RU2498796C2 |
| ORGANIC COMPOUNDS | 2012 |
|
RU2610094C2 |
| METHODS OF TREATING CANCER DISEASES AND TUMORS USING PDE1 INHIBITORS | 2019 |
|
RU2811918C2 |
| BI- AND POLYCYCLIC SUBSTITUTED ISOQUINOLINE AND ISOQUINOLINONE DERIVATIVES, USEFUL AS RHO-KINASE INHIBITORS | 2009 |
|
RU2532481C2 |
| AMINOGUAMIDINES, METHOD OF PREPARATION THEREOF, AND PHARMACEUTICAL COMPOSITION BASED THEREON | 1992 |
|
RU2095347C1 |
| DERIVATIVES OF 2-AMINO-4H-3,1-BENZOXAZINE-4-ONE FOR PROPHYLAXIS OR TREATMENT OF OBESITY OR ACCOMPANYING DISORDER | 2000 |
|
RU2244711C2 |
| SUBSTITUTED PIPERIDINE DERIVATIVES AND PHARMACEUTICAL COMPOSITION | 1998 |
|
RU2198172C2 |
| CONDENSED HETEROCYCLIC COMPOUND | 2009 |
|
RU2480473C2 |
